Skip to main content
Clinical Trials/DRKS00012930
DRKS00012930
Completed
未知

Effects of 3-months whole-body vibration training (WBV) in patients with interstitial lung disease: a randomized clinical trial. - WBV and fibrosis

niversitätsklinikum Gießen und Marburg GmbHZentrum für Innere Medizin Schwerpunkt Pneumologie0 sites27 target enrollmentApril 18, 2019

Overview

Phase
未知
Intervention
Not specified
Conditions
J84
Sponsor
niversitätsklinikum Gießen und Marburg GmbHZentrum für Innere Medizin Schwerpunkt Pneumologie
Enrollment
27
Status
Completed
Last Updated
last year

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
April 18, 2019
End Date
August 18, 2017
Last Updated
last year
Study Type
Interventional
Sex
All

Investigators

Sponsor
niversitätsklinikum Gießen und Marburg GmbHZentrum für Innere Medizin Schwerpunkt Pneumologie

Eligibility Criteria

Inclusion Criteria

  • Inclusion criteria were: the diagnoses of ILD, idiopathic pulmonary fibrosis (IPF), Idiopathic nonspecific interstitial pneumonia (NSIP), acute interstitial pneumonia (AIP), Cryptogenic organizing pneumonia (COP) or Sarcoidosis, written informed consent.

Exclusion Criteria

  • \- no pulmonary fibrosis
  • \- sarcoidosis
  • \- withdrawn consent
  • \- Indication of acute pathological cardiac events in the laboratory or ECG (TNI or CK increase, new ST segment changes).
  • \- Concomitant diseases such as heart failure (NYHA III and IV) or COPD
  • \- decompensated cardiac insufficiency
  • \- high blood pressure (\>220/120 mmHg)
  • \- more serious mental illnesses
  • \- cognitive limitations
  • \- Restrictions of the musculoskeletal system that make training with the Galileo impossible:

Outcomes

Primary Outcomes

Not specified

Similar Trials